Bridget S. Wilkins

Hydroxyurea Compared with Anagrelide in High-Risk Essential Thrombocythemia

Claire Harrison, Peter J. Campbell, Georgina Buck et al. · New England Journal of Medicine · 2005 · 910 citations · Full text

Survival Outcomes and Prognostic Factors in Mycosis Fungoides/Sézary Syndrome: Validation of the Revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer Staging Proposal

Nita Agar, Emma Wedgeworth, Siobhan Crichton et al. · Journal of Clinical Oncology · 2010 · 826 citations

Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study

Peter J. Campbell, Linda M. Scott, Georgina Buck et al. · The Lancet · 2005 · 643 citations

Thrombopoiesis, Immunohematology, Thrombosis +10

MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort

Philip Beer, Peter J. Campbell, Linda M. Scott et al. · Blood · 2008 · 419 citations · Full text

Guidelines for the diagnosis, investigation and management of polycythaemia/erythrocytosis

Mary Frances McMullin, D. Bareford, Peter J. Campbell et al. · British Journal of Haematology · 2005 · 334 citations